You can buy or sell ZIOP and other stocks, options, ETFs, and crypto commission-free!
ZIOPHARM Oncology Inc Common Stock, also called Ziopharm Oncology, is a biopharmaceutical company, which engages in the development, acquisition, and commercialization of immuno-oncology platforms that leverage cell- and gene-based therapies to treat patients with cancer. Its pipeline includes Sleeping Beauty TCR-T Targeting neoantigens; Ad-RTS-hlL-12 + veledimex; and Sleeping Beauty CAR-T. Read More The company was founded on September 9, 2003 and is headquartered in Boston, MA. The listed name for ZIOP is ZIOPHARM Oncology Inc Common Stock.
52 Week High
52 Week Low
— per share
Expected Nov 5, After Hours